← All companies

HQL

Abrdn Life Sciences Investors

HQL NYSE EDGAR ↗

$18.49

-0.41 -2.17%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$15.21 – $22.67

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Changed accountants Sep 12, 2023

8-K Other events Mar 25, 2013

8-K Other events Mar 23, 2012

8-K Other events Jun 30, 2011

8-K Other events May 3, 2011

8-K Other events Nov 2, 2010

8-K Other events Apr 6, 2010

8-K Other events Sep 30, 2009

8-K Other events Aug 4, 2009

8-K Other events Jul 18, 2008

Other filings

40-17G Sep 24, 2026

NPORT-P Aug 28, 2026

N-PX Aug 21, 2026

4 OWNERSHIP DOCUMENT Jul 20, 2026

3 OWNERSHIP DOCUMENT Jun 11, 2026

N-CSRS Jun 8, 2026

NPORT-P May 29, 2026

DEF 14A Apr 7, 2026

SCHEDULE 13G/A Mar 6, 2026

NPORT-P Feb 27, 2026

SCHEDULE 13D/A Feb 23, 2026

SCHEDULE 13D/A Feb 11, 2026

SCHEDULE 13D/A Jan 8, 2026

3 OWNERSHIP DOCUMENT Dec 19, 2025

4 OWNERSHIP DOCUMENT Dec 18, 2025

N-CSR Dec 8, 2025

N-CEN Dec 8, 2025

NPORT-P Nov 26, 2025

SCHEDULE 13D/A Nov 24, 2025

SCHEDULE 13D/A Sep 26, 2025

4 PRIMARY DOCUMENT Sep 23, 2025

4 PRIMARY DOCUMENT Sep 19, 2025

4 PRIMARY DOCUMENT Sep 17, 2025

4 PRIMARY DOCUMENT Sep 15, 2025

4 PRIMARY DOCUMENT Sep 4, 2025

SCHEDULE 13D/A Sep 3, 2025

4 PRIMARY DOCUMENT Sep 2, 2025

N-PX Aug 29, 2025

NPORT-P Aug 28, 2025

4 PRIMARY DOCUMENT Aug 27, 2025